These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29874844)

  • 1. Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis.
    Yoshida K; Matsuzaki K; Murata M; Yamaguchi T; Suwa K; Okazaki K
    Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29874844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions.
    Yoshida K; Murata M; Yamaguchi T; Matsuzaki K; Okazaki K
    J Clin Med; 2016 Jan; 5(1):. PubMed ID: 26771649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β/Smad signaling during hepatic fibro-carcinogenesis (review).
    Yoshida K; Murata M; Yamaguchi T; Matsuzaki K
    Int J Oncol; 2014 Oct; 45(4):1363-71. PubMed ID: 25050845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells.
    Matsuzaki K
    Cell Tissue Res; 2012 Jan; 347(1):225-43. PubMed ID: 21626291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
    Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
    Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis C.
    Yamaguchi T; Matsuzaki K; Inokuchi R; Kawamura R; Yoshida K; Murata M; Fujisawa J; Fukushima N; Sata M; Kage M; Nakashima O; Tamori A; Kawada N; Tsuneyama K; Dooley S; Seki T; Okazaki K
    Hepatol Res; 2013 Dec; 43(12):1327-42. PubMed ID: 23458062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
    Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
    Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
    Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries.
    Yoshida K; Matsuzaki K
    Front Physiol; 2012; 3():53. PubMed ID: 22457652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma.
    Murata M; Yoshida K; Yamaguchi T; Matsuzaki K
    World J Gastroenterol; 2014 Nov; 20(41):15018-27. PubMed ID: 25386050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad3 gene C-terminal phosphorylation site mutation exacerbates CCl
    Yang J; Gong Y; Xu W; Li L; Shi Z; Wang Q; He Y; Zhang C; Luo C; Fang Z; Yang Y
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug; 394(8):1779-1786. PubMed ID: 34191114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients.
    Nakamura N; Yoshida K; Tsuda R; Murata M; Yamaguchi T; Suwa K; Ichimura M; Tsuneyama K; Matsuzaki K; Nakano T; Hirohara J; Seki T; Okazaki K; Gershwin ME; Naganuma M
    Front Biosci (Landmark Ed); 2021 Dec; 26(12):1480-1492. PubMed ID: 34994163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smad phospho-isoforms direct context-dependent TGF-β signaling.
    Matsuzaki K
    Cytokine Growth Factor Rev; 2013 Aug; 24(4):385-99. PubMed ID: 23871609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad Phospho-Isoforms for Hepatocellular Carcinoma Risk Assessment in Patients with Nonalcoholic Steatohepatitis.
    Suwa K; Yamaguchi T; Yoshida K; Murata M; Ichimura M; Tsuneyama K; Seki T; Okazaki K
    Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31991602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis.
    Yamaguchi T; Yoshida K; Murata M; Suwa K; Tsuneyama K; Matsuzaki K; Naganuma M
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review.
    Gong Y; Yang Y
    Life Sci; 2020 Sep; 256():117909. PubMed ID: 32512009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
    Boye A; Wu C; Jiang Y; Wang J; Wu J; Yang X; Yang Y
    J Ethnopharmacol; 2015 Jul; 169():219-28. PubMed ID: 25934513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
    Zhang C; Li L; Hou S; Shi Z; Xu W; Wang Q; He Y; Gong Y; Fang Z; Yang Y
    J Ethnopharmacol; 2021 Oct; 279():114350. PubMed ID: 34157326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad3 phosphoisoform-mediated signaling during sporadic human colorectal carcinogenesis.
    Matsuzaki K
    Histol Histopathol; 2006 Jun; 21(6):645-62. PubMed ID: 16528675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.